Andrew Barnell serves as the Co-Founder and Chief Executive Officer at Geneoscopy, a molecular diagnostics company. In this role, he leads efforts to improve the prevention, detection, and treatment of gastrointestinal diseases. He actively collaborates with entrepreneurs, investors, clinicians, and researchers who are dedicated to advancing healthcare practices.

Prior to co-founding Geneoscopy, Barnell gained experience in the financial sector.